echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Immunity: Xiao Yichuan's team and others reveal new DNA sensing pathways in CD4+ T cells and their regulatory mechanisms that mediate aging-related autoimmune diseases

    Immunity: Xiao Yichuan's team and others reveal new DNA sensing pathways in CD4+ T cells and their regulatory mechanisms that mediate aging-related autoimmune diseases

    • Last Update: 2021-03-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The aging of the population is a major social problem facing our country and the world at present.
    With the increase of age, the normal body will show an aging state, and the aging of the immune system is one of the prominent and important problems, and it is also prone to chronic chronic diseases in elderly individuals.
    An important cause of inflammation and autoimmune diseases.

    T cell-mediated adaptive immunity is the key driving force for the body to induce autoimmune inflammation.
    Although thymus atrophy caused by aging will reduce the initial T cell output, the number of peripheral T cells in the elderly does not decrease.
    The reason is Since peripheral T cells undergo steady-state proliferation and activation in the state of aging, however, the specific regulatory mechanism by which senescence induces steady-state proliferation of T cells and promotes the occurrence and development of autoimmune inflammation is unclear.

    On March 4, 2021, Xiao Yichuan's group from Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences and Zheng Mingyue's group from Shanghai Institute of Materia Medica, Chinese Academy of Sciences, published a titled Cytoplasmic DNA sensing by KU complex in aged CD4+ in Immunity.
    T cell potentiates T cell activation and aging-related autoimmune inflammation research papers.

    This study reveals that KU complex mediates DNA perception in CD4+ T cells, which in turn mediates the regulatory mechanism of aging-related autoimmune diseases.

    In this study, the research team found that there is a large accumulation of DNA in the cytoplasm of CD4+ T cells in old mice and humans, and this accumulated DNA will promote the proliferation and activation of CD4+ T cells induced by TCR, indicating that T cells Oneself will promote its function activation through DNA perception.

    Next, the research team used mass spectrometry combined with Western blotting to screen for proteins that bind to cytoplasmic DNA in T cells, and found that the DNA in T cells does not bind to cGAS, but to the KU complex.

    If the small molecule inhibitor STL127705 is used to block the binding of KU complex to DNA, it will significantly inhibit the proliferation and activation of CD4+ T cells induced by DNA, thereby alleviating the occurrence and development of autoimmune inflammation in old mice, indicating that DNA induction The activation of T cell function is indeed mediated by the KU complex sensing DNA.

    Further studies have found that the KU complex is expressed in large amounts in the cytoplasm of T cells.
    After recognizing DNA in CD4+ T cells, it can promote the phosphorylation and activation of DNA-PKcs, which in turn mediates the phosphorylation of T169 of ZAK and activates ZAK.
    Then phosphorylate AKT to activate the downstream mTOR pathway, thereby enhancing the proliferation and activation of CD4+ T cells.

    Therefore, the activation of the DNA sensing pathway mediated by the KU complex in CD4+ T cells is a key mechanism leading to the occurrence and development of autoimmune inflammation in aged mice.

    In order to explore therapeutic strategies to interfere with this newly discovered DNA sensing pathway to suppress aging-related autoimmune inflammation, the researchers used calorie restriction (CR) or simulated intermittent feeding (FMD) to treat elderly mice and found these two dieting patterns Can significantly reduce the DNA damage and cytoplasmic DNA accumulation of CD4+ T cells in old mice, thereby inhibiting the phosphorylation of ZAK-T169 and the activation of downstream AKT/mTOR signals, and finally inhibiting the activation of CD4+ T cells and aging-related Symptoms of autoimmune disease.

    Furthermore, based on the key protein kinase ZAK identified in the DNA sensing pathway, the researchers used deep learning combined with molecular simulation to screen from approximately 130,000 compound libraries to obtain a small molecule compound iZAK2 that can specifically inhibit the activity of ZAK kinase.
    It is found that iZAK2 can effectively inhibit DNA-induced CD4+ T cell proliferation and activation, thereby alleviating the pathological symptoms of autoimmune diseases in elderly mice.

    DNA sensing in aging CD4+ T cells promotes its activation and autoimmune inflammation.
    In summary, this study reveals that cGAS/STING-independent DNA sensing signaling pathways in aging CD4+ T cells can promote the activation and proliferation of T cells.
    And lead to the occurrence and development of aging-related autoimmune diseases.Further research and development of inhibitors that block DNA sensing signal transduction in T cells may be beneficial to clinical treatment of aging-related autoimmune diseases.

    It is reported that Wang Yan, a doctoral student at the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, is the first author of the paper, and researcher Xiao Yichuan and researcher Zheng Mingyue are the co-corresponding authors.

    This work was supported by Academician Shu Hongbing and Professor Zhong Bo of Wuhan University, Professor Li Tao of the National Protein Center (Beijing), Professor Xu Pinglong of Zhejiang University, Professor Xiao Hui of the Shanghai Pasteur Institute of the Chinese Academy of Sciences, Professor Ge Baoxue of Tongji University, and Chang Xing of West Lake University.
    The professor's strong support and help.

    Link to the paper: https://doi.
    org/10.
    1016/j.
    immuni.
    2021.
    02.
    003 is open to reprint this article is open to reprint: just leave a message in this article to inform 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.